geha glp-1 coverage Paving the way for expanded | Insights & Events geha glp 1 coverage GLP-1

Front Cell Dev Biol

Biologic therapies have transformed Crohn's disease management and include several FDA-approved options: TNF- inhibitors : Infliximab (Remicade), adalimumab (Humira), and certolizumab pegol (Cimzia) block tumor necrosis factor-alpha, a key pro-inflammatory cytokine

Protect and expand coverage in public programs

In 2026, the Trump administration will launch the self-pay platform TrumpRx.gov

Short answer, the one that matters: no meaningful human signal, the thyroid black box is a rodent-dose precaution (the same way the old estrogen black box was more politics than data), and we actually see lower rates of some cancers in people taking them

When you reconstitute a grey market vial , you are trusting that the powder inside is accurately dosed to the labeled amount